Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism.
Chellama JayakumariAbilash NairJabbar Puthiyaveettil KhadarDarvin V DasNandini PrasadS J JessyAnjana GopiPadmanabhan GuruprasadPublished in: Journal of the Endocrine Society (2019)
OWT benefits a majority of patients in the long-term treatment of thyroxine-resistant hypothyroidism, in the real-world setting.